Zobair M. Younossi, Maria Stepanova, Mazen Noureddin, Kris V. Kowdley, Simone I. Strasser, Anita Kohli, Peter Ruane, Mitchell L. Shiffman, Aasim Sheikh, Nadege Gunn, Stephen H. Caldwell, Ryan S. Huss, Robert P. Myers, Vincent Wai‐Sun Wong, Naim Alkhouri, Zachary Goodman, Rohit Loomba – 11 May 2021 – Patient‐reported outcomes (PROs) are important endpoints for clinical trials. The impact of investigational drugs on PROs of patients with advanced nonalcoholic steatohepatitis (NASH) was investigated.

Kimberly L. Yan, Antoinette S. Gomes, Phillip A. Monteleone, Robert S. Venick, Sue V. McDiarmid, Jorge H. Vargas, Douglas G. Farmer – 10 May 2021 – Postoperative biliary complications have been reported to occur in 10% to 33% of pediatric liver transplantation (LT) recipients. Percutaneous intervention has become the primary treatment method for these complications; however, the efficacy and outcomes of these patients have not been well studied.

Arun Valsan, Nipun Verma, Virendra Singh – 10 May 2021

Moritz Peiseler, Frank Tacke – 10 May 2021

Laure Elkrief, Marie Lazareth, Pierre‐Emmanuel Rautou – 10 May 2021

Yu Ri Im, Harriet Hunter, Dana Gracia Hahn, Amedine Duret, Qinrong Cheah, Jiawen Dong, Madison Fairey, Clarissa Hjalmarsson, Alice Li, Hong Kai Lim, Lorcán McKeown, Claudia‐Gabriela Mitrofan, Raunak Rao, Mrudula Utukuri, Ian A. Rowe, Jake P. Mann – 10 May 2021

Alexander Clevewood Ng – 9 May 2021

Yun Ma, Haibin Su, Muhammed Yuksel, Maria Serena Longhi, Mark J. McPhail, Pengyun Wang, Sanjay Bansal, Guan‐Wee Wong, Jonathon Graham, Li Yang, Richard Thompson, Derek G. Doherty, Nedim Hadzic, Yoh Zen, Alberto Quaglia, Michael A. Heneghan, Marianne Samyn, Diego Vergani, Giorgina Mieli‐Vergani – 9 May 2021

Andrew M. Moon, Brenda Curtis, Pranoti Mandrekar, Ashwani K. Singal, Elizabeth C. Verna, Oren K. Fix – 8 May 2021 – The Coronavirus Disease 2019 (COVID‐19) pandemic has exacted a heavy toll on patients with alcohol‐associated liver disease (ALD) and alcohol use disorder (AUD). The collective burden of ALD and AUD was large and growing, even before the COVID‐19 pandemic. There is accumulating evidence that this pandemic has had a large direct effect on these patients and is likely to produce indirect effects through delays in care, psychological strain, and increased alcohol use.

Miguel Angel Martinez, Sandra Franco – 8 May 2021 – Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) is a novel coronavirus that causes coronavirus disease 19 (COVID‐19), which has infected millions of people worldwide in only a few months. A minority, but significant number, of infected individuals require hospitalization and intensive care. From the start of this new virus pandemic, it was apparent that obese and/or diabetic individuals had a bad prognosis for COVID‐19 progression, strongly suggesting an association between liver disease and severe COVID‐19.